Press Release · Press Releases · Asia-Pacific
SM Investments earns third consecutive Five Golden Arrow Award
PASAY CITY, Philippines, Nov. 5, 2026 /PRNewswire/ -- SM Investments Corporation, the parent company of the SM Group, received the Five Golden Arrow Award from the Institute of Corporate Directors (ICD) for the third consecutive year, achieving the highest rating under the corporate...
This press release summary is reproduced from the issuer's public feed.
Read the full release at PR NewswireOriginal publisher: PR Newswire
Spotted an error? Request a correction · Corrections Policy
Related stories
ANDPAD Named to "NextGen Tech 30 2026" as One of Asia's 30 Leading Next-generation Growth Companies
TOKYO, Nov. 6, 2026 /PRNewswire/ -- ANDPAD Inc. (headquartered in Minato City, Tokyo; hereinafter "ANDPAD"), operator of the construction vertical AI "ANDPAD," has been recognized as one of Asia's 30 leading growth companies in the international awards program "NextGen Tech 30 2026."...
PR Newswire ·
Fermi's Co-Founder and Largest Shareholder, Toby Neugebauer: "Fermi's Shareholders, the Markets and Texas Voters Have Rejected Rick Perry and Fermi's 'We Can Do Whatever We Want' Board"
"Today should be Fermi's greatest day. Fermi was built on the understanding that voters do not want data centers on their grid. Fermi's stock should be soaring, as Fermi was designed specifically to protect Americans by supplying AI companies with private power, using private water and...
PR Newswire ·
Tool Changer. Game Changer. Bambu Lab präsentiert den H3C - die wegweisende neue Generation von 3D-Druckern
AUSTIN, Texas, 6. November 2026 /PRNewswire/ -- Bambu Lab stellt heute den H3C vor, den ersten Desktop-3D-Drucker der dritten Generation des Unternehmens. Der H3C basiert auf einer Swaptek™-Architektur mit neun Werkzeugen und beseitigt damit endlich den seit langem bestehenden Kompromiss...
PR Newswire ·
Lynk Pharmaceuticals Announces NMPA Acceptance of New Drug Application for Zemprocitinib in the Treatment of Rheumatoid Arthritis
SHANGHAI and HANGZHOU, China and BOSTON, Nov. 5, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, announced that the New Drug Application (NDA) for its core...
PR Newswire ·
2026 World Internet Conference Wuzhen Summit Opens
WUZHEN, China, Nov. 5, 2026 /PRNewswire/ -- A news report from CRI Online The 2026 World Internet Conference (WIC) Wuzhen Summit opened on November 3 in Wuzhen, Tongxiang City in Zhejiang Province, under the theme "Open Source and Openness, Joined Contribution and Shared Benefits —...
PR Newswire ·
INOVIO Announces Pricing of Approximately $75 Million Public Offering
PLYMOUTH MEETING, Pa., Nov. 5, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced the...
PR Newswire ·